MRPS18C
gene geneOn this page
Also known as MRPS18-1CGI-134FLJ11146FLJ22967bS18m
Summary
MRPS18C (mitochondrial ribosomal protein S18C, HGNC:16633) is a protein-coding gene on chromosome 4q21.23, encoding Small ribosomal subunit protein bS18m (Q9Y3D5). It is a selective cancer dependency (DepMap: 19.1% of cell lines).
Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 28S subunit protein that belongs to the ribosomal protein S18P family. The encoded protein is one of three that has significant sequence similarity to bacterial S18 proteins. The primary sequences of the three human mitochondrial S18 proteins are no more closely related to each other than they are to the prokaryotic S18 proteins. Pseudogenes corresponding to this gene are found on chromosomes 8p, 12p, 15q, and 22q.
Source: NCBI Gene 51023 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 17 total
- Cancer dependency (DepMap): dependent in 19.1% of screened cell lines
- MANE Select transcript:
NM_016067
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16633 |
| Approved symbol | MRPS18C |
| Name | mitochondrial ribosomal protein S18C |
| Location | 4q21.23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MRPS18-1, CGI-134, FLJ11146, FLJ22967, bS18m |
| Ensembl gene | ENSG00000163319 |
| Ensembl biotype | protein_coding |
| OMIM | 611983 |
| Entrez | 51023 |
Gene structure
Transcript identifiers
Ensembl transcripts: 19 — 15 protein_coding, 3 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000295491, ENST00000505525, ENST00000505719, ENST00000507019, ENST00000507349, ENST00000509571, ENST00000509970, ENST00000512375, ENST00000514581, ENST00000857155, ENST00000857156, ENST00000857157, ENST00000857158, ENST00000917303, ENST00000917304, ENST00000917305, ENST00000917306, ENST00000917307, ENST00000917308
RefSeq mRNA: 4 — MANE Select: NM_016067
NM_001297767, NM_001297769, NM_001297770, NM_016067
CCDS: CCDS3604, CCDS75159, CCDS77933
Canonical transcript exons
ENST00000295491 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001073312 | 83459740 | 83459797 |
| ENSE00001073317 | 83458346 | 83458429 |
| ENSE00001150201 | 83456058 | 83456177 |
| ENSE00001181017 | 83461121 | 83462298 |
| ENSE00001233635 | 83456909 | 83456958 |
| ENSE00003548320 | 83460973 | 83461032 |
Expression profiles
Bgee: expression breadth ubiquitous, 268 present calls, max score 95.86.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 50.5568 / max 775.5929, expressed in 1818 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 48609 | 48.9847 | 1817 |
| 48608 | 1.4993 | 992 |
| 203273 | 0.0728 | 29 |
Top tissues by expression
288 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| hindlimb stylopod muscle | UBERON:0004252 | 95.86 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 95.64 | gold quality |
| heart right ventricle | UBERON:0002080 | 95.34 | silver quality |
| biceps brachii | UBERON:0001507 | 95.32 | gold quality |
| monocyte | CL:0000576 | 94.95 | gold quality |
| calcaneal tendon | UBERON:0003701 | 94.85 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 94.69 | silver quality |
| mononuclear cell | CL:0000842 | 94.66 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 94.51 | gold quality |
| leukocyte | CL:0000738 | 94.50 | gold quality |
| body of tongue | UBERON:0011876 | 94.33 | gold quality |
| oral cavity | UBERON:0000167 | 94.18 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 93.80 | gold quality |
| muscle of leg | UBERON:0001383 | 93.45 | gold quality |
| gastrocnemius | UBERON:0001388 | 93.44 | gold quality |
| pons | UBERON:0000988 | 93.07 | gold quality |
| prefrontal cortex | UBERON:0000451 | 92.89 | gold quality |
| right adrenal gland | UBERON:0001233 | 92.84 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 92.83 | gold quality |
| islet of Langerhans | UBERON:0000006 | 92.78 | gold quality |
| left adrenal gland | UBERON:0001234 | 92.77 | gold quality |
| cardiac ventricle | UBERON:0002082 | 92.77 | gold quality |
| heart left ventricle | UBERON:0002084 | 92.75 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 92.72 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 92.51 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 92.25 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 92.22 | gold quality |
| adrenal gland | UBERON:0002369 | 92.20 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 92.16 | gold quality |
| adrenal cortex | UBERON:0001235 | 92.11 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 11.67 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
33 targeting MRPS18C, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3143 | 99.93 | 71.96 | 3104 |
| HSA-MIR-627-3P | 99.90 | 71.42 | 3316 |
| HSA-MIR-6857-5P | 99.87 | 65.32 | 985 |
| HSA-MIR-6515-3P | 99.82 | 68.19 | 1933 |
| HSA-MIR-577 | 99.78 | 69.13 | 2479 |
| HSA-MIR-3659 | 99.70 | 67.97 | 694 |
| HSA-MIR-6516-3P | 99.65 | 68.57 | 1238 |
| HSA-MIR-7159-5P | 99.53 | 72.12 | 2472 |
| HSA-MIR-543 | 99.52 | 69.03 | 2595 |
| HSA-MIR-4666A-5P | 99.41 | 69.72 | 1887 |
| HSA-MIR-4460 | 99.37 | 68.52 | 615 |
| HSA-MIR-7151-5P | 99.37 | 67.82 | 613 |
| HSA-MIR-4796-5P | 99.34 | 70.06 | 810 |
| HSA-MIR-1911-3P | 99.15 | 66.17 | 528 |
| HSA-MIR-421 | 98.90 | 67.04 | 1883 |
| HSA-MIR-4272 | 98.76 | 68.74 | 1810 |
| HSA-MIR-1-5P | 98.70 | 68.66 | 1017 |
| HSA-MIR-9500 | 98.62 | 66.54 | 1845 |
| HSA-MIR-1237-3P | 98.55 | 67.65 | 1423 |
| HSA-MIR-1246 | 98.54 | 66.21 | 959 |
| HSA-MIR-4450 | 98.26 | 68.35 | 725 |
| HSA-MIR-3179 | 98.22 | 65.90 | 1445 |
| HSA-MIR-3132 | 97.96 | 67.91 | 711 |
| HSA-MIR-450A-2-3P | 97.91 | 67.56 | 1459 |
| HSA-MIR-1255B-2-3P | 97.80 | 67.04 | 880 |
| HSA-MIR-556-5P | 97.75 | 66.17 | 473 |
| HSA-MIR-376C-3P | 97.63 | 68.88 | 1263 |
| HSA-MIR-4642 | 97.52 | 67.60 | 916 |
| HSA-MIR-937-5P | 97.43 | 68.39 | 667 |
| HSA-MIR-4693-5P | 97.35 | 67.02 | 1234 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 19.1% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 2)
- Overexpression of MRPS18C gene (that encode for bS18m protein) suppressed the molecular defects produced by this mtDNA mutation, recovering the complex I activity and reducing the reactive oxygen species produced by this complex to normal levels. (PMID:28526948)
- Expression pattern of MRPS18 family genes in gliomas. (PMID:34591434)
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Mrps18c | ENSMUSG00000016833 |
Protein
Protein identifiers
Small ribosomal subunit protein bS18m — Q9Y3D5 (reviewed: Q9Y3D5)
Alternative names: 28S ribosomal protein S18-1, mitochondrial, 28S ribosomal protein S18c, mitochondrial, Small ribosomal subunit protein bS18c
All UniProt accessions (5): D6RCM2, D6RE70, Q9Y3D5, H0Y9W2, H0YAG5
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. Component of the mitochondrial small ribosomal subunit (mt-SSU). Mature mammalian 55S mitochondrial ribosomes consist of a small (28S) and a large (39S) subunit. The 28S small subunit contains a 12S ribosomal RNA (12S mt-rRNA) and 30 different proteins. The 39S large subunit contains a 16S rRNA (16S mt-rRNA), a copy of mitochondrial valine transfer RNA (mt-tRNA(Val)), which plays an integral structural role, and 52 different proteins. bS18m has a zinc binding site.
Subcellular location. Mitochondrion.
Miscellaneous. There are 3 mitochondrial isoforms of bS18 in mammalia, localizing to 3 distinct sites in the mitoribosome. bS18m (bs18c, this protein) binds to the same site as bacterial bS18, mS40 (bS18b) binds to a novel location of the 28S small subunit, and mL66 (bS18a) binds to the 39S large subunit.
Similarity. Belongs to the bacterial ribosomal protein bS18 family.
RefSeq proteins (4): NP_001284696, NP_001284698, NP_001284699, NP_057151* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001648 | Ribosomal_bS18 | Family |
| IPR018275 | Ribosomal_bS18_CS | Conserved_site |
| IPR036870 | Ribosomal_bS18_sf | Homologous_superfamily |
Pfam: PF01084
UniProt features (10 total): helix 5, turn 2, transit peptide 1, chain 1, strand 1
Structure
Experimental structures (PDB)
76 structures, top 30 by resolution.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7QI4 | ELECTRON MICROSCOPY | 2.21 |
| 8CSS | ELECTRON MICROSCOPY | 2.36 |
| 7P2E | ELECTRON MICROSCOPY | 2.4 |
| 8RRI | ELECTRON MICROSCOPY | 2.4 |
| 9OLF | ELECTRON MICROSCOPY | 2.46 |
| 8CSQ | ELECTRON MICROSCOPY | 2.54 |
| 8CSR | ELECTRON MICROSCOPY | 2.54 |
| 6ZM6 | ELECTRON MICROSCOPY | 2.59 |
| 7QI5 | ELECTRON MICROSCOPY | 2.63 |
| 8CSP | ELECTRON MICROSCOPY | 2.66 |
| 7PNX | ELECTRON MICROSCOPY | 2.76 |
| 8ANY | ELECTRON MICROSCOPY | 2.85 |
| 8CST | ELECTRON MICROSCOPY | 2.85 |
| 6ZM5 | ELECTRON MICROSCOPY | 2.89 |
| 7PO0 | ELECTRON MICROSCOPY | 2.9 |
| 8K2A | ELECTRON MICROSCOPY | 2.9 |
| 9PGL | ELECTRON MICROSCOPY | 2.9 |
| 7PO1 | ELECTRON MICROSCOPY | 2.92 |
| 7PO3 | ELECTRON MICROSCOPY | 2.92 |
| 9PGF | ELECTRON MICROSCOPY | 2.93 |
| 6VMI | ELECTRON MICROSCOPY | 2.96 |
| 6RW4 | ELECTRON MICROSCOPY | 2.97 |
| 6VLZ | ELECTRON MICROSCOPY | 2.97 |
| 7QI6 | ELECTRON MICROSCOPY | 2.98 |
| 8QRN | ELECTRON MICROSCOPY | 2.98 |
| 9PSM | ELECTRON MICROSCOPY | 2.98 |
| 8OIS | ELECTRON MICROSCOPY | 3 |
| 9G5C | ELECTRON MICROSCOPY | 3 |
| 9G5D | ELECTRON MICROSCOPY | 3 |
| 9HFM | ELECTRON MICROSCOPY | 3 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9Y3D5-F1 | 80.53 | 0.61 |
Function
Pathways and Gene Ontology
Reactome pathways
7 pathways
| ID | Pathway |
|---|---|
| R-HSA-5368286 | Mitochondrial translation initiation |
| R-HSA-5389840 | Mitochondrial translation elongation |
| R-HSA-5419276 | Mitochondrial translation termination |
| R-HSA-9937383 | Mitochondrial ribosome-associated quality control |
| R-HSA-392499 | Metabolism of proteins |
| R-HSA-5368287 | Mitochondrial translation |
| R-HSA-72766 | Translation |
MSigDB gene sets: 135 (showing top):
GOBP_MITOCHONDRIAL_TRANSLATION, GOBP_TRANSLATION, WEI_MYCN_TARGETS_WITH_E_BOX, MILI_PSEUDOPODIA_HAPTOTAXIS_UP, GOMF_STRUCTURAL_CONSTITUENT_OF_RIBOSOME, GOCC_MITOCHONDRIAL_ENVELOPE, WONG_MITOCHONDRIA_GENE_MODULE, ZHANG_BREAST_CANCER_PROGENITORS_UP, GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS, chr4q21, GOCC_RIBOSOME, GOCC_SMALL_RIBOSOMAL_SUBUNIT, GOCC_ORGANELLAR_RIBOSOME, GOCC_MITOCHONDRIAL_MATRIX, GOCC_ORGANELLE_INNER_MEMBRANE
GO Biological Process (2): translation (GO:0006412), mitochondrial translation (GO:0032543)
GO Molecular Function (2): structural constituent of ribosome (GO:0003735), small ribosomal subunit rRNA binding (GO:0070181)
GO Cellular Component (5): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), mitochondrial small ribosomal subunit (GO:0005763), ribosome (GO:0005840), ribonucleoprotein complex (GO:1990904)
Reactome top-level categories
Rollup of top-3 pathways:
| Category | Pathways |
|---|---|
| Mitochondrial translation | 4 |
| Translation | 1 |
| Metabolism of proteins | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| peptidyltransferase activity | 1 |
| translational initiation | 1 |
| translational elongation | 1 |
| translational termination | 1 |
| macromolecule biosynthetic process | 1 |
| protein metabolic process | 1 |
| protein biosynthetic process | 1 |
| mitochondrion | 1 |
| translation | 1 |
| mitochondrial gene expression | 1 |
| structural molecule activity | 1 |
| ribosome | 1 |
| rRNA binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| organellar small ribosomal subunit | 1 |
| mitochondrial ribosome | 1 |
| mitochondrial protein-containing complex | 1 |
| intracellular membraneless organelle | 1 |
| protein-containing complex | 1 |
Protein interactions and networks
STRING
2380 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MRPS18C | MRPS18A | Q9NVS2 | 980 |
| MRPS18C | MRPL50 | Q8N5N7 | 648 |
| MRPS18C | MRPS14 | O60783 | 640 |
| MRPS18C | MRPL42 | Q9Y6G3 | 587 |
| MRPS18C | MRPL24 | Q96A35 | 558 |
| MRPS18C | MRPS6 | P82932 | 555 |
| MRPS18C | MRPS18B | Q9Y676 | 545 |
| MRPS18C | MRPL20 | Q9BYC9 | 543 |
| MRPS18C | MRPL1 | Q9BYD6 | 543 |
| MRPS18C | MRPS9 | P82933 | 542 |
| MRPS18C | MRPL16 | Q9NX20 | 534 |
| MRPS18C | MRPL51 | Q4U2R6 | 522 |
| MRPS18C | COQ7 | Q99807 | 455 |
| MRPS18C | MTG1 | Q9BT17 | 455 |
| MRPS18C | MRPL53 | Q96EL3 | 450 |
IntAct
116 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NOP53 | RRP8 | psi-mi:“MI:0914”(association) | 0.640 |
| NOL12 | RRP8 | psi-mi:“MI:0914”(association) | 0.640 |
| MRPS27 | MRPS14 | psi-mi:“MI:0914”(association) | 0.640 |
| LIN28A | IGF2BP3 | psi-mi:“MI:0914”(association) | 0.640 |
| MRPS6 | STAT5A | psi-mi:“MI:0914”(association) | 0.550 |
| ZNF707 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| RPL18 | NOP56 | psi-mi:“MI:0914”(association) | 0.530 |
| ZBTB48 | ZBTB24 | psi-mi:“MI:0914”(association) | 0.530 |
| E4F1 | ZBTB24 | psi-mi:“MI:0914”(association) | 0.530 |
| RPL6 | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
| TRMT10B | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
| PDGFB | DKC1 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS18B | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPL2 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| CCDC59 | GAPDHS | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS34 | ZZEF1 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS18C | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS11 | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
| ABT1 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS26 | MRPS10 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS34 | MRPS12 | psi-mi:“MI:0914”(association) | 0.530 |
| VTN | HAT1 | psi-mi:“MI:0914”(association) | 0.530 |
BioGRID (233): MRPS18C (Affinity Capture-RNA), MRPS18C (Affinity Capture-RNA), MRPS18C (Affinity Capture-MS), MRPS18C (Affinity Capture-MS), MRPS18C (Affinity Capture-MS), MRPS18C (Affinity Capture-MS), MRPS18C (Affinity Capture-MS), MRPS18C (Affinity Capture-MS), MRPS18C (Affinity Capture-MS), MRPS18C (Affinity Capture-MS), MRPS18C (Affinity Capture-MS), MRPS18C (Affinity Capture-MS), MRPS18C (Co-fractionation), MRPS18C (Affinity Capture-MS), MRPS18C (Affinity Capture-MS)
ESM2 similar proteins: A1L1F1, A4IHH4, A6H773, F1QWK4, O08776, P09925, P82923, Q08BI9, Q12851, Q148G5, Q15526, Q2HJI2, Q2KID9, Q2NL34, Q3T056, Q4FZX0, Q4KLZ1, Q4R8P0, Q4V7A9, Q5CZL1, Q5EA03, Q5EBA1, Q5REX5, Q5XGM5, Q5ZLJ4, Q61161, Q6DFN1, Q6DIS1, Q6PE15, Q7ZU92, Q800L1, Q80YD1, Q810A5, Q8BSF4, Q8R2L5, Q91WM2, Q921N7, Q924T2, Q96B77, Q99N87
Diamond homologs: A1A3H9, A2C261, A2RCR6, A3CL34, A4VXF9, A4W3Q0, A5VP26, A6MVX7, A6U7G6, A6WWE5, A7FZG9, A8AZD5, A8YW49, A9KKC8, A9M8X7, B0CKD8, B0UL30, B1ICV9, B1LYI3, B1MWV2, B2IR58, B2S9V3, B3PUT6, B3W6R6, B4U153, B5E6A4, B5YEW7, B5ZWC8, B8E0J0, B8IED1, B8ZLD9, B9DVK2, B9JCB8, C0MB81, C0MEL9, C0R3A3, C0RHG1, C1C8C8, C1CFC0, C1CLN8
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| MRPS18C | “form complex” | “28S mitochondrial small ribosomal subunit” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 130 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Mitochondrial translation | 19 | 30.4× | 3e-21 |
| Mitochondrial translation initiation | 19 | 28.0× | 6e-21 |
| Mitochondrial translation elongation | 19 | 28.0× | 6e-21 |
| Mitochondrial ribosome-associated quality control | 19 | 27.1× | 9e-21 |
| Mitochondrial translation termination | 19 | 24.3× | 7e-20 |
| Translation | 22 | 15.9× | 4e-19 |
| Peptide chain elongation | 9 | 13.3× | 6e-07 |
| Viral mRNA Translation | 9 | 13.3× | 6e-07 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| mitochondrial translation | 21 | 30.4× | 5e-23 |
| translation | 19 | 16.3× | 2e-15 |
| cytoplasmic translation | 9 | 13.9× | 4e-06 |
| rRNA processing | 7 | 8.3× | 4e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
17 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 15 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1365 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:83456056:G:GT | donor_gain | 1.0000 |
| 4:83456105:G:GA | donor_gain | 1.0000 |
| 4:83456116:G:GT | donor_gain | 1.0000 |
| 4:83456176:GG:G | donor_gain | 1.0000 |
| 4:83456177:GG:G | donor_gain | 1.0000 |
| 4:83456903:TCGCA:T | acceptor_loss | 1.0000 |
| 4:83456904:CGCAG:C | acceptor_loss | 1.0000 |
| 4:83456907:A:AG | acceptor_gain | 1.0000 |
| 4:83456907:AGT:A | acceptor_gain | 1.0000 |
| 4:83456907:AGTG:A | acceptor_loss | 1.0000 |
| 4:83456908:G:GA | acceptor_gain | 1.0000 |
| 4:83456908:GT:G | acceptor_gain | 1.0000 |
| 4:83456908:GTG:G | acceptor_gain | 1.0000 |
| 4:83456908:GTGCT:G | acceptor_gain | 1.0000 |
| 4:83456959:G:GG | donor_gain | 1.0000 |
| 4:83458344:A:AG | acceptor_gain | 1.0000 |
| 4:83458345:G:GG | acceptor_gain | 1.0000 |
| 4:83458345:GCCC:G | acceptor_gain | 1.0000 |
| 4:83459721:A:AG | acceptor_gain | 1.0000 |
| 4:83459723:A:AG | acceptor_gain | 1.0000 |
| 4:83459724:T:G | acceptor_gain | 1.0000 |
| 4:83459725:A:AG | acceptor_gain | 1.0000 |
| 4:83459726:A:G | acceptor_gain | 1.0000 |
| 4:83460967:TTACA:T | acceptor_loss | 1.0000 |
| 4:83460968:TACA:T | acceptor_loss | 1.0000 |
| 4:83460969:ACAGG:A | acceptor_loss | 1.0000 |
| 4:83460970:CA:C | acceptor_loss | 1.0000 |
| 4:83460971:AGG:A | acceptor_loss | 1.0000 |
| 4:83460972:G:A | acceptor_loss | 1.0000 |
| 4:83463488:ACTT:A | donor_loss | 1.0000 |
AlphaMissense
925 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 4:83458420:G:C | K75N | 0.998 |
| 4:83458420:G:T | K75N | 0.998 |
| 4:83459752:T:C | F83L | 0.998 |
| 4:83459754:T:A | F83L | 0.998 |
| 4:83459754:T:G | F83L | 0.998 |
| 4:83459771:G:A | G89E | 0.997 |
| 4:83461020:G:C | A114P | 0.997 |
| 4:83461021:C:A | A114D | 0.997 |
| 4:83459753:T:C | F83S | 0.996 |
| 4:83461143:G:C | K125N | 0.996 |
| 4:83461143:G:T | K125N | 0.996 |
| 4:83459744:T:C | L80S | 0.995 |
| 4:83459771:G:T | G89V | 0.994 |
| 4:83461121:G:A | G118E | 0.994 |
| 4:83461008:G:C | A110P | 0.993 |
| 4:83461032:G:T | G118W | 0.992 |
| 4:83459746:T:C | S81P | 0.991 |
| 4:83459756:T:A | V84D | 0.991 |
| 4:83461012:T:A | I111N | 0.991 |
| 4:83459744:T:G | L80W | 0.990 |
| 4:83459741:T:C | L79P | 0.989 |
| 4:83460976:T:A | L99H | 0.989 |
| 4:83461032:G:A | G118R | 0.989 |
| 4:83461032:G:C | G118R | 0.989 |
| 4:83459753:T:G | F83C | 0.988 |
| 4:83460976:T:C | L99P | 0.988 |
| 4:83460991:A:C | Q104P | 0.988 |
| 4:83461016:G:C | K112N | 0.988 |
| 4:83461016:G:T | K112N | 0.988 |
| 4:83460978:T:C | C100R | 0.987 |
dbSNP variants (sampled 300 via entrez): RS1000298100 (4:83459086 C>G,T), RS1001546832 (4:83460092 A>G), RS1001882506 (4:83458246 G>T), RS1001919987 (4:83457979 G>A), RS1002178162 (4:83460076 A>G), RS1002567013 (4:83456411 C>T), RS1003307043 (4:83455351 G>A), RS1003456050 (4:83461517 G>A), RS1003895186 (4:83461093 G>T), RS1004397906 (4:83458078 C>T), RS1004520178 (4:83458736 G>A), RS1004700753 (4:83457034 G>A,C), RS1004774844 (4:83458324 G>C), RS1005198891 (4:83461957 A>G), RS1005229888 (4:83461568 T>C)
Disease associations
OMIM: gene MIM:611983 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
37 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Leflunomide | decreases expression | 2 |
| dicrotophos | decreases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| sodium arsenite | increases abundance, increases expression | 1 |
| isobutyl alcohol | affects cotreatment, decreases expression, increases abundance | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 4-phenylbutyric acid | decreases expression | 1 |
| cylindrospermopsin | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| K 7174 | decreases expression | 1 |
| Grape Seed Proanthocyanidins | affects cotreatment, decreases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| MT19c compound | increases expression | 1 |
| Acetaminophen | affects cotreatment, decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Arsenic | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | increases expression, increases abundance | 1 |
| Cannabidiol | increases expression | 1 |
| Catechin | affects cotreatment, decreases expression | 1 |
| Gasoline | affects cotreatment, decreases expression, increases abundance | 1 |
| Lead | affects splicing | 1 |
| Lipopolysaccharides | affects cotreatment, decreases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Polycyclic Aromatic Hydrocarbons | decreases expression, increases abundance, affects cotreatment | 1 |
| Ribonucleotides | affects binding | 1 |
| Rotenone | decreases expression | 1 |
| Smoke | decreases expression, increases abundance | 1 |
| T-2 Toxin | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.